Oxford Particle Imaging Centre (OPIC) is located in the Henry Wellcome Building for Particle Imaging and forms part of the Division of Structural Biology (STRUBI) within the Nuffield Department of Clinical Medicine.
The biosafety containment facility allows scientists to study pathogenic human and animal viruses, using a range of imaging, structural biology and biophysical techniques.
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Huang K-YA. et al, (2022), THERANOSTICS, 12, 1 - 17
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Dejnirattisai W. et al, (2021), Lancet (London, England)
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2021)
Bacteriophage PRD1 as a nanoscaffold for drug loading.
Duyvesteyn HME. et al, (2021), Nanoscale
Focus of our researchTo understand the biology of viruses and how they infect their host cells, it is important to be able to study the viruses in their infectious native state and also in their cellular context.
Groups in OPIC focus in studying structures of purified virus particles and virus host-cell interactions. OPIC houses state-of-the-art biosafety containment laboratories at ACDP category 3 and DEFRA 4 levels of containment. This facilitates the study of a number of viruses that are important to human and animal health.
Examples of our research
STRUCTURAL CELL BIOLOGY OF VIRUS INFECTION
Kay Grünewald - Our aim is a comprehensive picture of the functional interaction between viral protein complexes and cellular structures in the course of the infection. Viruses being studied include Herpes simplex virus type 1 and HIV. Read full biography
STRUCTURES AND HOST CELL INTERACTIONS OF EMERGING VIRUSES
Juha Huiskonen - We study the ultrastructure and cell entry mechanisms of viruses causing heamorrhagic fevers. Current focus is members of Arenaviridae (Lassa virus) and Bunyaviridae (Rift Valley fever virus). Read full biography
A PIPELINE FOR STRUCTURAL VACCINOLOGY
Dave Stuart - We use atomic resolution structures of viral particles to guide the design of stabilized vaccines. This ‘structural vaccinology’ approach is used for the development of a safe, synthetic stabilised virus-like particle (VLP) based vaccine for foot and-mouth disease virus and poliovirus. Read full biography
OPIC in a nutshell
Biosafety containment (ACDP3/DEFRA4)
Electron cryo-microscopy and tomography
Virus production and purification
Live cell imaging
Access to this facility can be made directly through email@example.com Please see Access Tab for pricing and further information.
Access for European researchers is also available through the Instruct-ERIC (pan-European Research Infrastructure in Structural Biology). Free at point of use through peer review.